OR WAIT null SECS
August 06, 2021
Novavax and European Commission have finalized an agreement to purchase up to 200 million doses of a COVID-19 vaccine.
Metrics Contract Services announces the completion of a $10 million expansion to their Greenville, NC facilities.
Catalent finalizes their acquisition of iPSC developer and manufacturer RheinCell Therapeutics.
Syngene International appoints two US-based executives to senior level positions.
August 05, 2021
TriRx continues to expand its manufacturing capabilities with the acquisition of the Elanco Animal Health Facility in Shawnee, Kansas.
BMG Pharma's clinical trial has demonstrated positive results in the efficacy of BMG0705 Nasal Spray and BMG0703A Mouth Rinse as treatments for asymptomatic COVID-19 patients.
Evonik has acquired the German biotech company JeNaCell, expanding its biomaterials portfolio.
Nanoform and Boehringer Ingelheim have executed a master services agreement in relation to pre-clinical development projects.
A research collaboration will combine Imugene’s oncolytic virus technology with Celularity’s allogeneic CAR T-cell therapy.
EC has confirmed that the entry into application of the Clinical Trials Regulation and, as such, the go-live date for the Clinical Trials Information System (CTIS) will be Jan. 31, 2022.